Background: Although intra-articular corticosteroid injections (CSIs) are a cornerstone in the nonoperative management of hip pathology, recent reports have raised concerns that they …
ML Angotti, RA Burnett, S Khalid… - Hip …, 2023 - journals.sagepub.com
Background: Intra-articular corticosteroid injections are commonly administered for hip pain. However, guidelines are conflicting on their efficacy, particularly in patients without arthritis …
P Rana, A Johnson, J Turcotte… - Journal of Orthopaedic …, 2024 - ncbi.nlm.nih.gov
Conclusion: In conclusion, this case series highlights the rare adverse outcome of rapidly progressive hip OA and FHC following IA corticosteroid injections and possible risk factors …
Sickle cell disease is a well-known homozygous inherited hemoglobinopathy that causes vaso-occlusive phenomena and chronic hemolysis. Vaso-occlusion results in sickle cell …
W Li, Z Huang, B Tan, G Chen, X Li, K Xiong, R Zhu… - 2021 - papers.ssrn.com
Background: Coronavirus disease 2019 (COVID-19) is an emerging global medical challenge and glucocorticoids remain the most promising therapy. Osteonecrosis (ON) is a …
Hip osteoarthritis (OA) is a prevalent disease that affects older adults and poses detrimental consequences on mobility and quality of life. Among those who will live until the age of 85 …